secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2026-06-08T21:15:17+00:00
Accession:  0001213900-26-066364
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics closes $8.5M private placement with warrants for up to $23.7M total
--------------------------------------------------------------------------------

- Closed private placement of 3,655,917 common shares (or pre-funded warrants) plus Series G and H warrants at $2.325/unit, raising $8.5M gross.
- Net proceeds of ~$7.7M after placement agent fees; cash runway extended into Q1 2027, beyond expected FDA submission.
- If all warrants exercised for cash, additional $15.2M proceeds would extend cash runway well beyond FDA approval and first year of commercialization.
- Company must file resale registration statement by June 17, 2026 for underlying shares; warrants have exercise price $2.075.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390026066364/0001213900-26-066364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390026066364/ea0293390-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-066364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer